{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-024697","form_type":"8-K","ticker":"FNCHQ","cik":"0001733257","company_name":"Finch Therapeutics Group, Inc.","filed_at":"2022-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.919907+00:00","generated_at":"2026-06-21T20:43:04.871940+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Finch Therapeutics posts updated corporate presentation to website on November 14, 2022","bullets":["Updated corporate presentation posted on November 14, 2022 under 'Events & Presentations' section of Finch's website.","Presentation covers general business update and microbiome pipeline; no specific financial or clinical data disclosed.","No earnings, guidance, or material operational milestones announced in this 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-024697","json":"https://secwatch.observer/filing/0000950170-22-024697.json","markdown":"https://secwatch.observer/filing/0000950170-22-024697.md","text":"https://secwatch.observer/filing/0000950170-22-024697.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1733257/000095017022024697/0000950170-22-024697-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1733257/000095017022024697/fnch-20221114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T20:43:04.871940+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}